Health Care & Life Sciences » Biotechnology | BioTie Therapies Oyj

BioTie Therapies Oyj

BioTie Therapies Oyj
Stock Exchange Other OTC
EPS
-
Market Cap
-
Shares Outstanding
1.09 B
Public Float
-

Profile

Address
420 Saw Mill River Road
Ardsley New York 10502
United States
Employees -
Website http://www.acorda.com
Updated 09/14/2018
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury.

Financials

View All

Ronald Cohen
President, Chief Executive Officer & Director
Catherine D. Strader
Independent Director